AIBullisharXiv – CS AI · Jun 97/10
🧠Researchers introduce AMix-1, a 1.7-billion parameter protein foundation model that uses Bayesian Flow Networks to advance computational protein design and engineering. The model demonstrates predictable scaling laws, in-context learning capabilities, and test-time scaling algorithms that enable the design of protein variants with up to 50x improved activity, establishing a framework for lab-in-the-loop protein engineering.
AINeutralWired – AI · Jun 47/10
🧠OpenAI, Anthropic, and other AI industry leaders have signed a letter to lawmakers advocating for improved tracking and regulation of synthetic DNA sequences to prevent their misuse in developing biological weapons. The initiative reflects growing concern within the AI community about dual-use risks associated with advanced AI capabilities.
🏢 OpenAI🏢 Anthropic
AIBullisharXiv – CS AI · Jun 27/10
🧠Researchers introduce AgentPLM, a protein language model enhanced with real-time biophysical feedback and tool integration to generate optimized protein sequences. The system combines reasoning-augmented decoding with a novel training approach, achieving state-of-the-art performance on enzyme design, antibody optimization, and structural stability tasks.
AINeutralarXiv – CS AI · Jun 235/10
🧠A new arXiv paper proposes a unified theoretical framework for understanding agency by grounding it in temporal organization, relational biology, and process ontology. The framework distinguishes between autonomy, goal-directedness, agency, and open-endedness through formalized timescale analysis, with implications for understanding biological systems, synthetic life, and artificial intelligence.
AINeutralarXiv – CS AI · Jun 106/10
🧠Researchers introduce Flexible Flows, an advanced generative framework for designing biological sequences using Discrete Flow Matching with structured couplings and latent edit-based parameterization. The method enables variable-length DNA and peptide sequence generation with fine-grained control while achieving state-of-the-art performance across multiple biological design tasks.
AINeutralarXiv – CS AI · Jun 95/10
🧠Researchers have developed Montparnasse, a Monte Carlo-based algorithm that significantly improves RNA sequence design for synthetic biology and medicine. The framework outperforms existing state-of-the-art methods like DesiRNA by solving benchmark tests three times faster while generating RNA sequences with superior structural properties.
AINeutralFortune Crypto · Jun 56/10
🧠CEOs from OpenAI, Anthropic, and Microsoft have jointly urged Congress to implement mandatory screening for synthetic DNA sales, citing AI's capability to accelerate bioweapon design and creation. The unusual collaboration among competing AI firms highlights shared concerns about dual-use AI technology and biosecurity risks that may require regulatory intervention.
🏢 OpenAI🏢 Anthropic
AIBullishCrypto Briefing · Jun 26/10
🧠Microsoft has launched its Discovery platform in partnership with Ginkgo Bioworks, a synthetic biology company, to accelerate scientific research and development processes. The integrated platform combines Microsoft's computational capabilities with Ginkgo's laboratory infrastructure, potentially transforming how organizations conduct R&D by increasing efficiency and speed.
AINeutralarXiv – CS AI · Jun 26/10
🧠Researchers introduce GeoCoupling, a framework that optimizes how different molecular modalities (protein sequences and structures) are temporally coupled during AI model training and generation. The approach outperforms existing synchronous coupling methods in biomolecular co-design tasks, producing molecules with improved physical validity and diversity for drug design and protein engineering applications.
AINeutralarXiv – CS AI · May 115/10
🧠Researchers propose using pulse-width modulation (PWM) with reinforcement learning to optimize optogenetic bioprocess control, enabling precise gene expression tuning through light-based switching rather than intensity adjustment. This approach addresses the limitation of steep dose-response curves in biotechnology by alternating light ON/OFF states within control periods, improving controllability and production efficiency in protein synthesis and metabolic regulation.
AIBullisharXiv – CS AI · Mar 26/1014
🧠Researchers have developed GenAI-Net, a generative AI framework that automates the design of chemical reaction networks (CRNs) for synthetic biology applications. The system can automatically generate biomolecular circuits for various functions including logic gates, oscillators, and classifiers, potentially accelerating the development of biomanufacturing and therapeutic technologies.
AIBullishIEEE Spectrum – AI · Feb 46/104
🧠Google DeepMind has launched AlphaGenome, an AI tool that analyzes the 98% of human DNA that doesn't code for proteins but regulates gene expression. The deep-learning platform can predict 11 types of biological signals and is already being used by thousands of scientists worldwide for cancer research, drug discovery, and synthetic DNA design.
$LINK$NEAR
AINeutralMIT News – AI · Feb 114/106
🧠Drug-resistant infections are increasing due to antibiotic overuse and misuse, while development of new antibacterial treatments has slowed. Synthetic biology and AI are being explored as potential solutions to address the growing global antimicrobial resistance threat.
